Actively Recruiting
The Epidemiological and Intrinsic Characteristics of Chronic Rhinitis
Led by Zheng Liu ENT · Updated on 2024-06-10
150000
Participants Needed
1
Research Sites
170 weeks
Total Duration
On this page
Sponsors
Z
Zheng Liu ENT
Lead Sponsor
P
Peking Union Medical College
Collaborating Sponsor
AI-Summary
What this Trial Is About
Chronic rhinitis affects 10-40% of China's population, or over 300 million people, and can lead to respiratory and psychological issues. Despite treatment progress, 30% of patients have poor outcomes, likely due to the disease's complexity and a lack of new treatment targets. The incidence is rising, but there's a lack of nationwide studies on its variations. This study addresses this through a multicentric survey to create a national database on chronic rhinitis, including epidemiological, clinical, and biological data. The goal is to understand chronic rhinitis's causes and risks, improve treatments, and develop preventive strategies. The study will survey 30,000 patients across China, using questionnaires and nasal exams, and preserve biological samples in a biobank for detailed analysis. This will lay the groundwork for understanding the disease's mechanisms, developing new diagnostics, and tailoring prevention and treatment approaches for different forms of chronic rhinitis.
CONDITIONS
Official Title
The Epidemiological and Intrinsic Characteristics of Chronic Rhinitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Chinese individuals aged 18 to 70 years
- Resided at the survey site for more than 6 months within the 12 months before the survey
You will not qualify if you...
- Residents in specialized facilities such as workshops, military barracks, student dormitories, or nursing homes
- Individuals with mental or cognitive disorders including dementia, aphasia, or deafness
- Individuals who have had sinus or nasal surgery or been diagnosed with sinusitis, nasal polyps, or nasal/nasopharyngeal tumors in the past year
- Patients with cystic fibrosis or primary ciliary dyskinesia
- Individuals currently receiving treatment for newly diagnosed tumors
- Volunteers deemed unsuitable for the study by the research team
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tongji Hosptial affiliated to Tongji Medical college of Huazhong University of Science and Technology
Wuhan, Hubei, China, 430030
Actively Recruiting
Research Team
Z
Zheng Liu, PI
CONTACT
N
Nan Wang, SubI
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here